Connect with us

JAMMU & KASHMIR

Spare hospitals for severe cases of Coronavirus: DAK | KNO

Published

on

kno news

Srinagar Mar 31 (KNO): Doctors Association Kashmir (DAK) on Tuesday has urged health authorities in Kashmir valley to spare hospitals for patients who have severe disease from the novel (new) coronavirus. “Most people infected with the novel virus do not require hospitalization,” said DAK President Dr Nisar ul Hassan in a statement issued to wire service—Kashmir News Observer (KNO). “We need to reserve hospital infrastructure and manpower for those who need them. We can’t pile up those who don’t need to be in hospitals and leave no beds for those who actually need them,” he said. Dr Nisar said patients who are positive for COVID-19 and have mild disease can stay in isolation at home for 2 weeks and contact their health care provider by phone for guidance about clinical management. These patients may just need a Paracetamol and they recover on their own. “However, older patients and those with underlying medical conditions should be observed in hospitals, even if they have milder illness given the possible risk of progression to severe illness in them,” he said. “Persons who have history of travel or contact with a confirmed case after screening should be quarantined either at home or at a designated community center. In no case should they occupy hospital beds,” he added. Dr Nisar said only those patients who have severe disease should get admitted to a hospital so that the work force at hospitals can focus on the most critical cases. He said mild cases are those who have symptoms of fever and cough, but are stable and have no pneumonia or hypoxia. Severe cases have difficulty in breathing and are hypoxic, and critical cases have respiratory and other organ failure. Quoting a large study of 44,000 patients from china, Dr Nisar said 81 percent had mild disease, 14 percent had severe disease and 5 percent had critical illness. “In this study, all deaths occurred among patients with critical illness. While overall case fatality rate was 2.3 percent, the case fatality rate among patients with critical disease was 49 percent,” he said “Kashmir valley has, so far reported 43 laboratory confirmed cases and two deaths due to the novel (new) coronavirus,” said Dr Nisar – (KNO)

Trending

TOP STORIES7 hours ago

Kashmir braces for rain, snow as Gulmarg, Pahalgam shiver at -3.5°C | KNO

TOP STORIES7 hours ago

Harud Festival showcases Kashmir’s rich cultural heritage at Gulmarg | KNO

TOP STORIES7 hours ago

AIMSA sets Nov 18 deadline on PG residents’ stipend revision | KNO

TOP STORIES7 hours ago

CAG flags Rs 4.17 lakh tax irregularity involving Srinagar-based firm under Vivad Se Vishwas Scheme | KNO

TOP STORIES7 hours ago

J&K Govt approves Rs 22.71 crore to revive stalled Batamaloo Mini Secretariat | KNO

TOP STORIES7 hours ago

FDA conducts 108 inspections across J&K, suspends licences of three establishments | KNO

TOP STORIES7 hours ago

Kulgam Terror Attack: Courage displayed by jawans foiled nefarious designs of terrorists: Special DG CRPF | KNO

TOP STORIES7 hours ago

CRPF T20 Cricket Cup kicks off in Srinagar, 16 teams in fray | KNO

TOP STORIES7 hours ago

Govt notifies new timing for Kashmir schools | KNO

TOP STORIES7 hours ago

Guns no longer roar in every lane of Kashmir: BJP leader | KNO

TOP STORIES7 hours ago

Govt notifies new timing for Kashmir schools | KNO

TOP STORIES7 hours ago

623 MW power deficit likely during peak winters in J&K, Ladakh | KNO

TOP STORIES7 hours ago

44 Percent consultant posts, 25 Percent medical officer posts vacant in J&K healthcare institutions | KNO

TOP STORIES7 hours ago

Finance Department tells departments to ensure timely payment of electricity dues | KNO

TOP STORIES7 hours ago

Minister Sakina Itoo talks tough on food safety violations | KNO

TOP STORIES7 hours ago

Non-gazetted employees of 5 new GMCs resume protest over non-finalisation of service rules | KNO

TOP STORIES7 hours ago

LoP Sharma seeks S-VYASA’s support to tackle drug menace in J&K | KNO

Copyright © 2021